Patent · US Expired

Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation

US5783591A · kind A · utility

4Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 1994
Grant dateJul 21, 1998
Priority date
Expiry dateNov 17, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical preparations for the local treatment of inflammations are claimed herein, characterized in that they contain as the active ingredient one or two compounds of general Formula I ##STR1## wherein X is an oxygen atom or a methylene group, PA1 R.sub.1 and R.sub.2 represent a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally interrupted by an oxygen atom, PA1 R.sub.3 is a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally substituted by an oxo group, and PA1 R.sub.4 is a hydrogen atom or an alkyl group of maximally four carbon atoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.